PPD Inc. shares PPD, +13.78% soared 14% in their trading debut Thursday, after the drug research company's initial public offering priced at the high end of its $24 to $27 price range. The company sold 60 million shares to raise $1.62 billion. Sixteen banks underwrote the deal, led by Barclays, JPMorgan, Morgan Stanley and Goldman Sachs. Proceeds of the deal will be used to pay down debt and for general corporate purposes.
#div-gpt-ad-1569967089584-0 > div > iframe { width: 100% !important; min-width: 300px; max-width: 800px; }
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: